Gilead Sciences Profit Margin

Gilead Sciences (GIS.DE) currently reports a profit margin of -12.22% as of September 2026. That compares with 27.88% in the prior-year period — down 143.8% year over year. That is below the Healthcare sector average of 10.58%. Use the charts on this page to explore Gilead Sciences's profit margin history and peer comparisons.

Gilead Sciences's profit margin decreased from 27.88% to -12.22% — a 143.8% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Gilead Sciences's profit margin of -12.22% is lower than the Healthcare sector average of 10.58%. That is roughly 215.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Gilead Sciences's current -12.22% should be judged against Healthcare norms (sector average: 10.58%) and against GIS.DE's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -12.22%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 10.58%. From there, open related valuation or income-statement pages for Gilead Sciences, and consider following GIS.DE for alerts when major investors trade the stock.